| 28.53 0.24 (0.85%) | 09-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 35.89  |
1-year : | 37.74 |
| Resists | First : | 30.73 |
Second : | 32.31 |
| Pivot price | 29.89 |
|||
| Supports | First : | 28.17 |
Second : | 23.43 |
| MAs | MA(5) : | 28.89 |
MA(20) : | 30.36 |
| MA(100) : | 30.52 |
MA(250) : | 32.17 |
|
| MACD | MACD : | -0.6 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 5  |
D(3) : | 4.9 |
| RSI | RSI(14): 36.9 |
|||
| 52-week | High : | 41.84 | Low : | 23.1 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ USNA ] has closed above bottom band by 8.7%. Bollinger Bands are 6.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 28.63 - 28.82 | 28.82 - 28.99 |
| Low: | 27.69 - 27.94 | 27.94 - 28.16 |
| Close: | 28.15 - 28.54 | 28.54 - 28.88 |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Wed, 24 Sep 2025
USANA Health Sciences, Inc. (USNA) Launches an Upgraded Celavive Skincare Line, Features Refreshed Formulations and Five New Products - Yahoo
Wed, 24 Sep 2025
USANA Health Sciences (NYSE:USNA) Downgraded to "Hold" Rating by Zacks Research - MarketBeat
Tue, 23 Sep 2025
USANA Health Sciences, Inc. $USNA Shares Sold by Rhumbline Advisers - MarketBeat
Fri, 19 Sep 2025
USANA Health takes controlling stake in Hiya - MSN
Mon, 15 Sep 2025
Is USANA Health Sciences (USNA) a Great Value Stock Right Now? - Yahoo Finance
Thu, 11 Sep 2025
USANA Launches Next-Generation Celavive Skincare: Advanced Formulas, Expert Ambassadors, Proven Results - Sahm
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 18 (M) |
| Shares Float | 10 (M) |
| Held by Insiders | 42.9 (%) |
| Held by Institutions | 61.2 (%) |
| Shares Short | 705 (K) |
| Shares Short P.Month | 736 (K) |
| EPS | 1.79 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 29.07 |
| Profit Margin | 3.7 % |
| Operating Margin | 7 % |
| Return on Assets (ttm) | 5.1 % |
| Return on Equity (ttm) | 6.3 % |
| Qtrly Rev. Growth | 10.8 % |
| Gross Profit (p.s.) | 39.34 |
| Sales Per Share | 49.21 |
| EBITDA (p.s.) | 4.37 |
| Qtrly Earnings Growth | -3.8 % |
| Operating Cash Flow | 63 (M) |
| Levered Free Cash Flow | 62 (M) |
| PE Ratio | 15.85 |
| PEG Ratio | 0 |
| Price to Book value | 0.98 |
| Price to Sales | 0.57 |
| Price to Cash Flow | 8.27 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|